Aspirin-exacerbated respiratory disease.


Journal

Current opinion in immunology
ISSN: 1879-0372
Titre abrégé: Curr Opin Immunol
Pays: England
ID NLM: 8900118

Informations de publication

Date de publication:
10 2020
Historique:
received: 11 02 2020
accepted: 28 02 2020
pubmed: 17 4 2020
medline: 5 10 2021
entrez: 17 4 2020
Statut: ppublish

Résumé

Aspirin-exacerbated respiratory disease (AERD) classically presents with severe asthma, nasal polyposis, and respiratory exacerbations in response to cyclooxygenase (COX)-1 inhibition. Recent advances in our understanding of AERD have revealed multiple facets of immune dysregulation, including diminished prostaglandin E2 (PGE

Identifiants

pubmed: 32299015
pii: S0952-7915(20)30022-4
doi: 10.1016/j.coi.2020.02.006
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-13

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Hannah Wangberg (H)

Division of Allergy, Asthma, and Immunology, Scripps Clinic, San Diego, CA, United States.

Andrew A White (AA)

Division of Allergy, Asthma, and Immunology, Scripps Clinic, San Diego, CA, United States. Electronic address: White.Andrew@scrippshealth.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH